PERSPECTA

News from every angle

← Back to headlines

Healthcare ETF Comparison: iShares Pharma vs. VanEck Biotech

A comparative analysis evaluates whether iShares Pharma or VanEck Biotech presents a better investment opportunity within the healthcare exchange-traded fund (ETF) sector.

20 Aug, 21:34 — 20 Aug, 21:34
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual5d ago

In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?

Read full article →

Related Stories

Par Pacific to Sell Laramie Energy Assets for $485 Million

44m ago

Multiple Company Executives Sell Significant Shares in Their Respective Firms

45m ago

Box Reports Strong Q2 2026 Revenue, Lifts Full-Year Outlook

50m ago

Franklin Templeton and Franklin Can Low Volatility ETF Announce Dividends

52m ago